Providing a New Approach to Patient Care: A Conversation with Pieter Mutendam from scPharmaceuticals
September 19th 2016At the Heart Failure Society of America's 20th Annual Scientific Meeting, Pieter Muntendam, MD, scPharmaceuticals, discussed his work in developing a hospital strength treatment option for patients with fluid overload using the well known drug furosemide, now for subcutaneous administration.
Read More
Larry Allen, MD: The Rebirth in Heart Failure
September 18th 2016"Heart failure is a disease that happens because of other diseases, so it's kind of the end result of diabetes, heart attacks, and cancer therapies, so it's hard to be a heart failure doctor and not spend a lot of time thinking about all the other medical specialties," concluded Allen.
Read More
Larry Allen, MD: Benefits of Shared Decision Making in Heart Failure Patients
September 18th 2016With many new drug discoveries and medical devices int he field of advanced heart failure, Larry Allen, MD, MHS and his team are working to create patient decision support tools to help them navigate any challenges.
Read More
Adriana Garriga-Lopez: Celebrating Public Health with a Song, Literally
September 18th 2016Bonus video: As the 20th Annual US Conference on AIDS wound down, one presenter stood out—not just for advocacy work. She also sings. Here’s the conclusion of our interview with Adriana Garriga-Lopez, PhD, singing Manuel de Falla's "Nana".
Read More
Charles King, Housing Works: How Social Drivers Impact HIV/AIDS Epidemic
September 15th 2016According to Charles King, President and CEO of Housing Works, "It really doesn't matter what part of the world you're in. If you're having to struggle with issues around sexism, racism, homophobia, transphobia, homelessness, addiction, mental illness, they are all drivers of very bad health outcomes for people - whether you're talking about HIV, hepatitis C, or tuberculosis."
Read More
Ibrahim Danad, MD: PACIFIC Trial: Which Imaging Tool Has The Greatest Diagnostic Accuracy?
August 31st 2016At The European Society of Cardiology Congress 2016 (ESC), Ibrahim Danad, MD, VU University Medical Center, Amsterdam, Netherlands, explained the results from his team's PACIFIC trial, which assessed two non-invasive coronary artery imaging tools: positon emission tomography (PET) and single photon emission computed tomography (SPECT).
Read More
Anselm K. Gitt, MD: DYSIS and Increased Persistent Lipid Abnormalities
August 30th 2016At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Anselm Gitt, MD discussed the DYSIS program, which was designed to get an idea to see how patients were treated for secondary prevention, focusing on dyslipidemia patients.
Read More